Effect of Pimobendan in The Treatment of Pulmonary Hypertension in a Cat with Giant Right Atrium

Creative Commons License

Levent P., Sarıl A., Kocatürk M., Tanaka R., Yılmaz Z.

KAFKAS UNIVERSITESI VETERINER FAKULTESI DERGISI, vol.26, pp.717-718, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Letter
  • Volume: 26
  • Publication Date: 2020
  • Doi Number: 10.9775/kvid.2020.24524
  • Journal Name: KAFKAS UNIVERSITESI VETERINER FAKULTESI DERGISI
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, Veterinary Science Database, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.717-718
  • Bursa Uludag University Affiliated: Yes

Abstract

Pulmonary hypertension (PH) is one of the most common

health problem in human medicine, therefore many

patients need anti-hypertensive medication to improve

clinical signs and increase life quality and expectancy. In

veterinary medicine, PH is associated with heartworm

disease, pulmonary thromboembolism, chronic obstructive

pulmonary disease, left-sided heart failure and large

congenital cardiac shunts in dogs, but is rarely reported in

cats [1-4]. Therefore, by this case presentation, we would like

to share diagnostic algorithm and therapeutic approach

of PH with veterinary academicians and practitioners

to develop their skills on challenging disorders of feline

cardiology.